Skip to content

Drug interactions

Canagliflozin-metformin + Olmesartan

Severity: Moderate

Canagliflozin-metformin and Olmesartan: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Angiotensin receptor blockers raise serum potassium and can reduce renal function, particularly with volume depletion from canagliflozin. Combined use may increase the risk of hyperkalemia and acute kidney injury, which also raises the risk of metformin accumulation.

What this interaction means in plain words

Canagliflozin-metformin and Olmesartan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Canagliflozin-metformin belongs to Endocrine; Olmesartan belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

ARB-induced reduction of aldosterone effect with additive hemodynamic renal effects from SGLT2 inhibition.

What to do

Check potassium, creatinine and volume status after starting or adjusting therapy. Reassess metformin if eGFR declines markedly.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Canagliflozin-metformin and Olmesartan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Canagliflozin-metformin with Olmesartan?

MediHelp rates the interaction as moderate. Canagliflozin-metformin and Olmesartan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Angiotensin receptor blockers raise serum potassium and can reduce renal function, particularly with volume depletion from canagliflozin. Combined use may increase the risk of hyperkalemia and acute kidney injury, which also raises the risk of metformin accumulation.

How serious is the interaction between Canagliflozin-metformin and Olmesartan?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check potassium, creatinine and volume status after starting or adjusting therapy. Reassess metformin if eGFR declines markedly.

What other medicines interact with Canagliflozin-metformin?

MediHelp also lists interactions of Canagliflozin-metformin with, for example, Contrast media, Diatrizoate, Diatrizoate meglumine / diatrizoate. The full list is on the Canagliflozin-metformin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in